Bone mineral density and bone turnover in relation to serum leptin, alpha-ketoglutarate and sex steroids in overweight and obese postmenopausal women.

Abstract:

OBJECTIVE:Recent studies have shown that parallel changes in body weight and bone mass can be partially mediated via circulating leptin. Therefore, among the hormones involved in bone and mineral metabolism, such as oestrogens, testosterone and parathormone, leptin has recently become a subject of considerable interest. The aim of this study was to assess associations between leptin, E(2), testosterone, dehydroepiandrosterone sulphate (DHEA-S), SHBG, alpha-ketoglutaric acid (AKG) and bone mineral density (BMD) and bone turnover markers in overweight and obese postmenopausal women. DESIGN:Eighty healthy, postmenopausal Caucasian women were studied. BMD of the lumbar spine (L(2)-L(4)) and femoral neck regions were examined using the dual X-ray absorptiometry (DXA) method. Associations were evaluated in stepwise multiple regression analysis, including information on the possible confounders and effect modifiers, for example, age, years since menopause, height and weight. RESULTS:Femoral neck BMD was positively correlated with weight (r = 0.52, P < 0.000001), body mass index (BMI) (r = 0.48, P < 0.000006), hipline (r = 0.48, P < 0.00006), waistline (r = 0.45, P < 0.00002) and DHEA-S (r = 0.36, P < 0.0008). Correlations of E(2), SHBG, testosterone and leptin, as well as biochemical markers of bone turnover with L(2)-L(4) and femoral neck BMD were not found. In the whole study group, significant predictors of L(2)-L(4 )BMD were BMI (beta = 0.35, P < 0.01) testosterone (beta = 0.27, P < 0.05) and osteocalcin (OC) (beta = 0.22, P < 0.05) (R(2) = 0.23), while predictors of femoral neck BMD were BMI (beta = 0.42, P < 0.001), testosterone (beta = 0.24, P < 0.05), E(2) (beta = 0.19, P < 0.05), as well as osteocalcin (beta = 0.20, P < 0.05) (R(2) = 0.41). In the subgroup with BMI 30-39.9, the significant predictors of both L(2)-L(4 )and femoral neck BMD were testosterone (beta = 0.32, P < 0.05, R(2) = 0.19; beta = 0.33, P < 0.05, R(2) = 0.29) and osteocalcin (beta = 0.34, P < 0.05, R(2) = 0.19; beta = 0.45, P < 0.01, R(2) = 0.29). In the subgroup with waist : hip ratio (WHR > or = 0.85, the predictor of L(2)-L(4 )BMD was E(2) (beta = 0.38, P < 0.05) (R(2) = 0.21), whereas the predictors of femoral neck BMD were BMI (beta = 0.29, P < 0.05) and testosterone (beta = 0.35, P < 0.01) (R(2) = 0.36). CONCLUSION:The main endocrine variable predicting lumbar spine BMD in overweight and obese postmenopausal females was testosterone, while the main determinants of femoral neck BMD were both testosterone and E(2). No effect was found of serum leptin on examined indicators of bone status.

journal_name

Clin Endocrinol (Oxf)

journal_title

Clinical endocrinology

authors

Filip R,Raszewski G

doi

10.1111/j.1365-2265.2008.03313.x

subject

Has Abstract

pub_date

2009-02-01 00:00:00

pages

214-20

issue

2

eissn

0300-0664

issn

1365-2265

pii

CEN3313

journal_volume

70

pub_type

杂志文章
  • Glycoprotein hormone alpha-subunit and prolactin release by cultured pituitary adenoma cells from acromegalic patients: correlation with GH release.

    abstract::In-vitro data of pituitary adenoma cells from 28 acromegalic patients were evaluated. In addition to GH, PRL was produced by 16 adenomas (57%) and alpha-subunit by 15 adenomas (54%) while there was a significantly higher incidence of tumours producing PRL and alpha-subunit simultaneously. From 26 pituitary adenomas en...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.1989.tb00264.x

    authors: Hofland LJ,van Koetsveld PM,Verleun TM,Lamberts SW

    更新日期:1989-06-01 00:00:00

  • 'Low T3 syndrome' in patients chronically treated with an iodine-containing drug, amiodarone.

    abstract::Cardiac patients treated with the iodine-containing drug 'amiodarone' undergo a significant iodine overload which can last for months after the drug has been withdrawn. Some patients develop hyperthyroidism and others hypothyroidism. In the hyper- or hypothyroid patients, the indices of thyroid function are modified a...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.1978.tb03569.x

    authors: Jonckheer MH,Blockx P,Broeckaert I,Cornette C,Beckers C

    更新日期:1978-07-01 00:00:00

  • Final height outcome and value of height prediction in boys with constitutional delay in growth and adolescence treated with intramuscular testosterone 125 mg per month for 3 months.

    abstract:OBJECTIVES:Constitutional delay in growth and adolescence (CDGA) is common in boys, some of whom request treatment to accelerate growth and attainment of secondary sexual characteristics. The aims of this study were to confirm that a 3-month course of intramuscular testosterone oenanthate does not impair final height i...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1046/j.1365-2265.2003.01692.x

    authors: Kelly BP,Paterson WF,Donaldson MD

    更新日期:2003-03-01 00:00:00

  • Maternal vitamin D supplementation during pregnancy prevents vitamin D deficiency in the newborn: an open-label randomized controlled trial.

    abstract:OBJECTIVE:To determine whether maternal vitamin D supplementation, in the vitamin D deficient mother, prevents neonatal vitamin D deficiency. DESIGN:Open-label randomized controlled trial. SETTING:Metropolitan Melbourne, Australia, tertiary hospital routine antenatal outpatient clinic. PARTICIPANTS:Seventy-eight wom...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章,随机对照试验

    doi:10.1111/cen.12762

    authors: Rodda CP,Benson JE,Vincent AJ,Whitehead CL,Polykov A,Vollenhoven B

    更新日期:2015-09-01 00:00:00

  • Growth hormone secretory pattern and response to treatment in children with short stature followed to adult height.

    abstract:OBJECTIVE:To compare the relative utility of GH stimulation tests and assays of spontaneous GH secretion as predictors of change in height standard deviation score at the end of GH treatment in children with short stature. PATIENTS AND METHODS:We retrospectively studied 116 children (67 boys and 49 girls) with subnorm...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1046/j.1365-2265.2003.01773.x

    authors: Radetti G,Buzi F,Cassar W,Paganini C,Stacul E,Maghnie M

    更新日期:2003-07-01 00:00:00

  • Vitamin D metabolites and their relationship to azotaemic osteodystrophy.

    abstract::Bone biopsies were performed and serum concentrations of vitamin D metabolites were measured in twenty-four patients with chronic renal failure. The concentrations of three metabolites--25-dihydroxyvitamin D (25-OHD), 24,25-dihydroxyvitamin D (24,25-OH2D) and 1,25-dihydroxyvitamin D (1,25-OH2D)--were significantly low...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.1980.tb03399.x

    authors: Mason RS,Lissner D,Wilkinson M,Posen S

    更新日期:1980-10-01 00:00:00

  • Increased thyrotrophin levels and loss of the nocturnal thyrotrophin surge in Sheehan's syndrome.

    abstract:OBJECTIVE:Since panhypopituitarism in patients with Sheehan's syndrome is due to massive pituitary necrosis with only minor hypothalamic involvement, we hypothesized that serum TSH levels would be low but its circadian rhythm preserved in these patients. DESIGN AND PATIENTS:Basal and TRH-stimulated mean afternoon (150...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1046/j.1365-2265.1997.2381042.x

    authors: Abucham J,Castro V,Maccagnan P,Vieira JG

    更新日期:1997-11-01 00:00:00

  • Reduced serum dehydroepiandrosterone levels in diabetic patients with hyperinsulinaemia.

    abstract:OBJECTIVE:To elucidate the interaction between insulin and dehydroepi-androsterone (DHEA) concentrations, we evaluated serum DHEA and DHEA-sulphate (DHEA-S) levels in diabetic patients with hyperinsulinaemia. PATIENTS AND DESIGN:Twenty-four subjects with non-insulin dependent diabetes mellitus, 12 hyperinsulinaemic su...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1046/j.1365-2265.1998.00533.x

    authors: Yamaguchi Y,Tanaka S,Yamakawa T,Kimura M,Ukawa K,Yamada Y,Ishihara M,Sekihara H

    更新日期:1998-09-01 00:00:00

  • IGF-I in a normal population: relation to psychosocial factors.

    abstract:OBJECTIVE:IGF-I has important actions on cell division, apoptosis, differentiation and metabolism, as well as on cell proliferation in vascular smooth muscle. Deficiency of GH, an important regulator of IGF-I, is associated with reduced well-being. IGF-I levels have been related to cognitive function in older individua...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1046/j.1365-2265.2002.01671.x

    authors: Unden AL,Elofsson S,Knox S,Lewitt MS,Brismar K

    更新日期:2002-12-01 00:00:00

  • Effects of the progestagen-only contraceptive implant Implanon on cardiovascular risk factors.

    abstract:OBJECTIVE:Epidemiological studies on the cardiovascular risk of progestagen-only contraceptives are rare. With the present study we aimed to investigate the effect of the low-dose etonogestrel-releasing contraceptive implant Implanon on cardiovascular risk factors, including markers of inflammation. DESIGN:Longitudina...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.2007.03046.x

    authors: Merki-Feld GS,Imthurn B,Seifert B

    更新日期:2008-03-01 00:00:00

  • The corticotropin-releasing hormone test in the diagnosis of ACTH-dependent Cushing's syndrome: a reappraisal.

    abstract:OBJECTIVE:Stimulation with corticotropin-releasing hormone (CRH) is one of principal tools for the differential diagnosis of ACTH-dependent Cushing's syndrome. However, different dosages and species of CRH may be employed; further, ACTH levels can be measured by radioimmunoassay (RIA) or immunoradiometric assay (IRMA)....

    journal_title:Clinical endocrinology

    pub_type: 杂志文章,多中心研究

    doi:10.1046/j.1365-2265.2001.01258.x

    authors: Pecori Giraldi F,Invitti C,Cavagnini F,Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-pituitary-adrenal axis.

    更新日期:2001-05-01 00:00:00

  • Nephrogenous cyclic AMP in primary hepatocellular carcinoma patients with or without hypercalcaemia.

    abstract:OBJECTIVE:To study the relationship between the excretion of nephrogenous cyclic AMP (NcAMP) and other blood and urine parameters as an index of PTH-like activity in patients with primary hepatocellular carcinoma. DESIGN:After overnight fast, a double voided urine and a blood sample were collected from each subject fo...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.1991.tb00939.x

    authors: Panesar NS,Au KM,Leung NW,Shek CC,Swaminathan R

    更新日期:1991-12-01 00:00:00

  • Aromatase deficiency: A case series of 46, XX Chinese children and a systematic review of the literature.

    abstract:BACKGROUND:Aromatase deficiency (AD) caused by cytochrome P450 family 19 subfamily A polypeptide 1 (CYP19A1) variants is characterized by a deficiency in androgen-to-oestrogen conversion. OBJECTIVE:To investigate the clinical characteristics and accurate management of aromatase-deficient children. PATIENTS AND METHOD...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/cen.14277

    authors: Fan L,Zhang B,Li L,Gong C

    更新日期:2020-12-01 00:00:00

  • Efficacy and safety of prenatal dexamethasone treatment in offspring at risk for congenital adrenal hyperplasia due to 21-hydroxylase deficiency: A systematic review and meta-analysis.

    abstract:OBJECTIVE:To assess the efficacy and safety of prenatal dexamethasone treatment in offspring at risk for congenital adrenal hyperplasia. METHODS:MEDLINE, EMBASE, the Cochrane Library, the clinicaltrials.gov website databases were systematically searched from inception through March 2019. WMD and SMD with 95%CIs were c...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/cen.14126

    authors: Xu L,Lin W,Cai L,Huang H,Liang J,Li L,Zong L,Wang N,Wen J,Chen G

    更新日期:2020-02-01 00:00:00

  • Relationship between insulin sensitivity and bone mineral density in primary hyperparathyroidism.

    abstract:INTRODUCTION:Evidence of crosstalk between bone and insulin metabolism has been identified. In primary hyperparathyroidism (PHPT), scant data exist on this relationship. AIM:To evaluate the relationship between insulin levels or sensitivity and bone mineral density (BMD) in PHPT. SUBJECT AND METHODS:Two hundred and s...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/cen.12472

    authors: Gianotti L,Tassone F,Baffoni C,Pellegrino M,Cassibba S,Castellano E,Magro G,Cesario F,Visconti G,Borretta G

    更新日期:2014-09-01 00:00:00

  • What is the optimal bone-preserving strategy for patients with Addison's disease?

    abstract::Addison's disease is associated with low bone mineral density and increased risk of hip fractures. Causes are multifactorial, contributed by underlying adrenocortical hormonal deficiency, associated autoimmune endocrinopathies, electrolyte disturbances and, in some patients, supraphysiologic glucocorticoid replacement...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/cen.12730

    authors: Lee P,Greenfield JR

    更新日期:2015-08-01 00:00:00

  • The cardiovascular effects of octreotide treatment in acromegaly: an echocardiographic study.

    abstract::Nine acromegalic patients were treated by the somatostatin analogue SMS 201-995 octreotide (Sandostatin (octreotide), Sandoz, Basle, Switzerland] 250 micrograms/day in 4 divided s.c. injections (50 + 50 + 50 + 100 micrograms) for 1 month, 250 micrograms/24 has continuous s.c. infusions for another month and thereafter...

    journal_title:Clinical endocrinology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1111/j.1365-2265.1989.tb00266.x

    authors: Thuesen L,Christensen SE,Weeke J,Orskov H,Henningsen P

    更新日期:1989-06-01 00:00:00

  • Use of GnRH agonist and human chorionic gonadotrophin tests for differentiating constitutional delayed puberty from gonadotrophin deficiency in boys.

    abstract:OBJECTIVES:The differentiation of constitutional delayed puberty (CDP) from gonadotrophin deficiency (GD) in boys at referral poses a difficult challenge. The effectiveness of the GnRH agonist (GnRH-a) test in distinguishing between the two conditions was evaluated and compared with findings of the GnRH and hCG stimula...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1046/j.1365-2265.2002.01520.x

    authors: Kauschansky A,Dickerman Z,Phillip M,Weintrob N,Strich D

    更新日期:2002-05-01 00:00:00

  • The development of transient hypothyroidism after iodine-131 treatment in hyperthyroid patients with Graves' disease: prevalence, mechanism and prognosis.

    abstract:OBJECTIVE:Recovery of thyroid function in patients following hypothyroidism induced by 131I therapy for Graves' disease has been described, but only a few detailed clinical and biochemical studies of this phenomenon (transient hypothyroidism) have been published. The prevalence, mechanism, and final outcome of transien...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1046/j.1365-2265.1997.d01-1737.x

    authors: Aizawa Y,Yoshida K,Kaise N,Fukazawa H,Kiso Y,Sayama N,Hori H,Abe K

    更新日期:1997-01-01 00:00:00

  • Symptoms of thyrotoxicosis, bone metabolism and occult atrial fibrillation in older women with mild endogenous subclinical hyperthyroidism.

    abstract:OBJECTIVE:The objective of this study was to evaluate symptoms of thyrotoxicosis, bone turnover, bone mineral density (BMD) and occult atrial fibrillation (AF) in women ≥65 years with mild endogenous subclinical hyperthyroidism (SCH). DESIGN:Cross-sectional and case-control study. PATIENTS:Signs and symptoms of thyro...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/cen.12979

    authors: Rosario PW,Carvalho M,Calsolari MR

    更新日期:2016-07-01 00:00:00

  • Biochemical and hormonal changes induced by one week of administration of rIGF-I to patients with Laron type dwarfism.

    abstract:OBJECTIVE:The purpose of this investigation was to evaluate the effectiveness of short-term administration of recombinant biosynthetic IGF-I on patients with an hereditary inability to generate this hormone. DESIGN AND PATIENTS:Ten patients with Laron type dwarfism (LTD) (4 males, six females) aged 3 1/2 to 37 3/4 yea...

    journal_title:Clinical endocrinology

    pub_type: 临床试验,杂志文章

    doi:10.1111/j.1365-2265.1991.tb03513.x

    authors: Laron Z,Klinger B,Jensen LT,Erster B

    更新日期:1991-08-01 00:00:00

  • Serum testosterone bioassay evaluation in a large male cohort.

    abstract:OBJECTIVE:To assess if a cell-based readout of androgen action in serum demonstrates a closer association with recognized classical parameters of androgen action in men than current measures of serum testosterone (T). DESIGN:To develop, validate and utilize a mammalian cell-based assay to measure specifically bioactiv...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.2009.03595.x

    authors: Need EF,O'Loughlin PD,Armstrong DT,Haren MT,Martin SA,Tilley WD,Florey Adelaide Male Aging Study.,Wittert GA,Buchanan G

    更新日期:2010-01-01 00:00:00

  • Detection of autoantibodies to recombinant human thyroid peroxidase by sensitive enzyme immunoassay.

    abstract::Autoantibodies to thyroid peroxidase (TPO), the thyroid 'microsomal' antigen, are widely utilized in the diagnosis of human autoimmune thyroid disease. Crude human thyroid preparations of TPO are of differing potency, contain residual thyroglobulin (Tg) and other human membrane antigens, and are available in only limi...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.1990.tb03912.x

    authors: Kendler DL,Martin A,Magnusson RP,Davies TF

    更新日期:1990-12-01 00:00:00

  • Prevalence of clinically silent corticotroph macroadenomas.

    abstract:OBJECTIVE:The prevalence of clinically silent corticotroph macroadenomas is unknown. Our aim was to determine the prevalence of clinically silent corticotroph macroadenomas among all pituitary macroadenomas. DESIGN:Patients scheduled to have transsphenoidal surgery for any sellar mass were prospectively evaluated clin...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/cen.13146

    authors: Guttenberg KB,Mayson SE,Sawan C,Kharlip J,Lee JY,Martinez-Lage M,Loevner LA,Ewanichak J,Grady MS,Snyder PJ

    更新日期:2016-12-01 00:00:00

  • Accuracy of ultrasonography to establish the diagnosis and aetiology of permanent primary congenital hypothyroidism.

    abstract:OBJECTIVE:To compare ultrasonography and 99mTc thyroid scintigraphy for the aetiologic diagnosis of permanent congenital hypothyroidism (CH). STUDY DESIGN:Eighty-eight consecutive patients with CH were recruited at an endocrinology outpatient clinic and submitted to high-frequency ultrasonography and to 99mTc scintigr...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1046/j.1365-2265.2003.01856.x

    authors: Kreisner E,Camargo-Neto E,Maia CR,Gross JL

    更新日期:2003-09-01 00:00:00

  • Novel mutations in the calcium-sensing receptor gene associated with biochemical and functional differences in familial hypocalciuric hypercalcaemia.

    abstract:OBJECTIVE:Heterozygous inactivating mutations of the calcium-sensing receptor (CaR) gene cause familial hypocalciuric hypercalcaemia (FHH), a generally benign disorder characterized by mild to moderate PTH-dependent hypercalcaemia. We aimed to identify the causative CaR mutations in three families with FHH and examine ...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.2006.02512.x

    authors: Ward BK,Magno AL,Blitvich BJ,Rea AJ,Stuckey BG,Walsh JP,Ratajczak T

    更新日期:2006-05-01 00:00:00

  • Does hypopituitarism recover when macroprolactinomas are treated with cabergoline?

    abstract:OBJECTIVE:The frequency and the degree of recovery of anterior pituitary hormone deficits in patients with macroprolactinoma responsive to cabergoline are not clear. Our aim was to evaluate pituitary function in these patients with particular reference to an assessment of the possible restoration of pituitary deficits....

    journal_title:Clinical endocrinology

    pub_type: 临床试验,杂志文章

    doi:10.1111/cen.12124

    authors: Karavitaki N,Dobrescu R,Byrne JV,Grossman AB,Wass JA

    更新日期:2013-08-01 00:00:00

  • Decreased sex hormone binding globulin (SHBG) and insulin-like growth factor binding protein (IGFBP-1) in extreme obesity.

    abstract::Obesity may be characterized by abnormal sex steroid secretion and reduced sex hormone binding globulin (SHBG) which in turn is related to fat distribution and insulin secretion. Recent in-vitro and in-vivo evidence suggests that insulin is the common mechanism regulating the secretion of SHBG and insulin-like growth ...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.1990.tb00507.x

    authors: Weaver JU,Holly JM,Kopelman PG,Noonan K,Giadom CG,White N,Virdee S,Wass JA

    更新日期:1990-09-01 00:00:00

  • Pyridostigmine fails to increase either spontaneous or GHRH-stimulated GH secretion during day or night in growth hormone-insufficient children.

    abstract::OBJECTIVE The aim of the study was to investigate whether pyridostigmine, a cholinesterase inhibitor which is thought to act at the hypothalamus to inhibit somatostatin secretion, would augment spontaneous or GHRH-stimulated serum GH levels in patients with GH-insufficiency. DESIGN Oral pyridostigmine 60 mg or placebo...

    journal_title:Clinical endocrinology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1111/j.1365-2265.1991.tb00313.x

    authors: Kirk JM,Ross RJ,Trainer PJ,Froud AL,Davies SC,Savage MO,Besser GM

    更新日期:1991-05-01 00:00:00

  • The IGF-I receptor sub-membrane domain is intact in GH-secreting pituitary tumours.

    abstract:BACKGROUND AND OBJECTIVE:Clinical acromegaly is characterized by dysregulation of somatotroph GH secretion in the presence of high circulating serum IGF-I levels. Physiologically, IGF-I exerts a negative feedback on GH secretion at both the hypothalamic and the pituitary levels. We have previously shown that the 943 an...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.1995.tb01858.x

    authors: Greenman Y,Prager D,Melmed S

    更新日期:1995-02-01 00:00:00